Cinacalcete is a substance widely used in the treatment of hyperparathyroidism because it has a calcium-like function, joining receptors located in the parathyroid glands, which are behind the thyroid.
In this way, the glands stop releasing an excess of PTH hormone, allowing calcium levels in the body to remain well regulated.
- Cinacalcete can be purchased from conventional pharmacies under the trade name Mimpara and is produced by Amgen laboratories in the form of 30.
- 60 or 90 mg tablets; however.
- There are also some formulations of the drug in generic form.
The price of Cinacalcete can vary between 700 reais, for 30 mg tablets, and 2000 reais, for 90 mg tablets. However, the generic version of the drug is usually lower in value.
Cinacalcete is indicated for the treatment of secondary hyperparathyroidism in patients with end-stage chronic kidney disease and dialysis.
In addition, it can also be used in cases of excess calcium caused by parathyroid carcinoma or primary hyperparathyroidism, when surgery to remove the glands is not possible.
The recommended dose of Cinacalcete varies depending on the problem to be treated:
Some of the most common side effects of using Cinacalcete include weight loss, loss of appetite, seizures, dizziness, tingling, headache, cough, shortness of breath, stomach pain, diarrhea, muscle pain and excessive fatigue.
This medicine should not be used by people allergic to Calcinete or any component of the formula.